S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Price:
427.4
HKD
0.38%
Market Closed
Market Cap:
HK$99.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
CN |
|
Playmates Toys Ltd
HKEX:869
|
HK |
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
Hindustan Petroleum Corp Ltd
NSE:HINDPETRO
|
IN |
|
T
|
Tanco Holdings Bhd
KLSE:TANCO
|
MY |
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
IE |
Cash Flow Statement
Cash Flow Statement
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Currency: CNY
| Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
0
|
(143)
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
91
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
148
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
103
|
0
|
0
|
|
| Cash Interest Paid |
(4)
|
2
|
0
|
6
|
|
| Change in Working Capital |
(540)
|
(481)
|
(734)
|
(180)
|
|
| Cash from Operating Activities |
(540)
N/A
|
(430)
+20%
|
(734)
-71%
|
(180)
+75%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(4)
|
(81)
|
(85)
|
(126)
|
|
| Other Items |
1 216
|
(741)
|
(549)
|
537
|
|
| Cash from Investing Activities |
1 211
N/A
|
(822)
N/A
|
(634)
+23%
|
411
N/A
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
(989)
|
1 094
|
2 379
|
1 777
|
|
| Net Issuance of Debt |
411
|
(55)
|
(37)
|
(43)
|
|
| Other |
4
|
(2)
|
(0)
|
(6)
|
|
| Cash from Financing Activities |
(574)
N/A
|
1 037
N/A
|
2 342
+126%
|
1 728
-26%
|
|
| Change in Cash | |||||
| Effect of Foreign Exchange Rates |
10
|
22
|
(1)
|
(51)
|
|
| Net Change in Cash |
107
N/A
|
(192)
N/A
|
972
N/A
|
1 907
+96%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(544)
N/A
|
(511)
+6%
|
(819)
-60%
|
(307)
+63%
|
|
Switch to:
Switch to:
See Also
Discover More
